Cargando…

Innate immune-mediated antiviral response to SARS-CoV-2 and convalescent sera a potential prophylactic and therapeutic agent to tackle COVID-19

The whole world is confronting the pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Unfortunately, there is no vaccine to prevent novel coronavirus infection. Besides several experimental drugs, the strong immune responses and convalescent sera are the current two potential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdullah, Faisal, Shah, Aman, Komal, Rahman, Anees ur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454257/ https://www.ncbi.nlm.nih.gov/pubmed/33912794 http://dx.doi.org/10.1093/abt/tbaa019

Ejemplares similares

Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies
por: de Wit, Emmie, et al.
Publicado: (2011)

The Use of Convalescent Sera in Immune-Electron Microscopy to Detect Non-Suspected/New Viral Agents
por: Lavazza, Antonio, et al.
Publicado: (2015)

Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera
por: Kannenberg, Judith, et al.
Publicado: (2021)

ELECTROPHORETIC STUDY OF ANTIVIRAL SERA
por: Koprowski, Hilary, et al.
Publicado: (1947)

Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes
por: Hein, Sascha, et al.
Publicado: (2021)

SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
por: Lusvarghi, Sabrina, et al.
Publicado: (2021)

Biofilm and planktonic pneumococci demonstrate disparate immunoreactivity to human convalescent sera
por: Sanchez, Carlos J, et al.
Publicado: (2011)

SARS corona virus peptides recognized by antibodies in the sera of convalescent cases
por: Guo, Jian-Ping, et al.
Publicado: (2004)

Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic
por: Mir, Iqra, et al.
Publicado: (2022)

Development of an ELISA for distinguishing convalescent sera with Mycoplasma hyopneumoniae infection from hyperimmune sera responses to bacterin vaccination in pigs
por: Ding, Honglei, et al.
Publicado: (2021)

Cold as a Therapeutic and Prophylactic Agent
por: Robinson, R. D.
Publicado: (1908)

Prophylactic treatment with bicillin-5 and timalin of convalescence of erysipelas
por: Iarovoi, Liviu, et al.
Publicado: (2013)

Infectious Disease: Tackling Innate Immunity
por: Potera, Carol
Publicado: (2004)

NEUTRALIZATION TESTS WITH SERA OF CONVALESCENT OR IMMUNIZED ANIMALS AND THE VIRUSES OF SWINE AND HUMAN INFLUENZA
por: Francis, Thomas, et al.
Publicado: (1936)

Seroepidemiologic study on convalescent sera from dengue fever patients in Jinghong, Yunnan
por: Ma, Yingshuo, et al.
Publicado: (2021)

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
por: Hu, Jie, et al.
Publicado: (2021)

Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera
por: Ha, Binh, et al.
Publicado: (2021)

Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera
por: Tada, Takuya, et al.
Publicado: (2021)

Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera
por: Hu, Jie, et al.
Publicado: (2021)

Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent
por: Zhang, Meng, et al.
Publicado: (2022)

Risk management strategies and therapeutic modalities to tackle COVID-19/SARS-CoV-2
por: Shah, Syed Muhammad Ali, et al.
Publicado: (2021)

Tackling obesity: new therapeutic agents for assisted weight loss
por: Karam, JG, et al.
Publicado: (2010)

High Heterogeneity of Virus-Neutralizing and RBD-Binding Activities of COVID-19 Convalescent Sera
por: Astakhova, E. A., et al.
Publicado: (2022)

Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type Proanthocyanidins
por: Maffei, Massimo E., et al.
Publicado: (2022)

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
por: Supasa, Piyada, et al.
Publicado: (2021)

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
por: Dupont, Liane, et al.
Publicado: (2021)

Multifunctional Spirogyra-hyalina-Mediated Barium Oxide Nanoparticles (BaONPs): Synthesis and Applications
por: Abdullah, et al.
Publicado: (2023)

Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent
por: de Oliveira, Jonatas Rafael, et al.
Publicado: (2019)

Vegetal Compounds as Sources of Prophylactic and Therapeutic Agents in Dentistry
por: Milutinovici, Raluca-Adriana, et al.
Publicado: (2021)

Bacteriophages as therapeutic & disinfectant agents to tackle multidrug-resistant Acinetobacter baumannii
por: Rathor, Nisha, et al.
Publicado: (2023)

BACTERIOSTATIC EFFECT OF HUMAN SERA ON GROUP A STREPTOCOCCI : I. TYPE-SPECIFIC ANTIBODIES IN SERA OF PATIENTS CONVALESCING FROM GROUP A STREPTOCOCCAL PHARYNGITIS
por: Rothbard, Sidney
Publicado: (1945)

SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera
por: Kuzmina, Alona, et al.
Publicado: (2021)

Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody
por: Yue, Shuai, et al.
Publicado: (2021)

Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents
por: Ma, Chengbao, et al.
Publicado: (2022)

Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera
por: Kruglova, Natalia, et al.
Publicado: (2021)

Development of an indirect ELISA for detecting humoral immunodominant proteins of Mycoplasma hyopneumoniae which can discriminate between inactivated bacterin-induced hyperimmune sera and convalescent sera
por: Ding, Honglei, et al.
Publicado: (2019)

Reproduction of contagious caprine pleuropneumonia reveals the ability of convalescent sera to reduce hydrogen peroxide production in vitro
por: Liljander, Anne, et al.
Publicado: (2019)

Therapeutic potential of coumarins as antiviral agents
por: Hassan, Mohd. Zaheen, et al.
Publicado: (2016)

Steep Decline in Binding Capability of SARS-CoV-2 Omicron Variant (B.1.1.529) RBD to the Antibodies in Early COVID-19 Convalescent Sera and Inactivated Vaccine Sera
por: Zhou, Wenhao, et al.
Publicado: (2022)

Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants
por: Banerjee, Arinjay, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4b8g6utahcd329aj9kgd1t1l49